FSRH Clinical Effective Unit response to Danish study on maternal use of oral contraceptives and risk of birth defects - 2016
Posted 1 January 2016
Date: 01 Jan 2016
Type: FSRH Clinical Guidance and Clinical Statements
Danish study on maternal use of oral contraceptives and risk of birth defects
FSRH’s Clinical Effectiveness Unit responds to the findings of a Danish database study, published in the BMJ, which finds no significant increase in the overall risk of major birth defects amongst babies whose mothers used oral contraceptives (OC) in the three months prior to conception or in early pregnancy.
Read the response in full below.